Ítem
Solo Metadatos

SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors

Mostrar el registro sencillo de la publicación
dc.creatorInciarte-Mundo, J.spa
dc.creatorHernández, M.spa
dc.creatorRuiz-Esquide, V.spa
dc.creatorRamírez, J.spa
dc.creatorCuervo, A.spa
dc.creatorAmaya, J.spa
dc.creatorPascal, M.spa
dc.creatorYagüe, J.spa
dc.creatorCañete, J.spa
dc.creatorSanmarti, R.spa
dc.date.accessioned2020-08-06T16:24:05Z
dc.date.available2020-08-06T16:24:05Z
dc.date.created2015-06spa
dc.description.abstractBackground Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1136/annrheumdis-2015-eular.3394
dc.identifier.issnISSN: 0959-8138
dc.identifier.issnEISSN: 1756-1833
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/26451
dc.language.isoengspa
dc.publisherBMJ Publishing Groupspa
dc.relation.citationIssueNo. Suppl 2
dc.relation.citationStartPage693
dc.relation.citationTitleAnnals of the Rheumatic Diseases
dc.relation.citationVolumeVol. 74
dc.relation.ispartofAnnals of the Rheumatic Diseases,ISSN:0959-8138 ; EISSN:1756-1833, Vol.74, No.Suppl 2 (2015-06); pp.693spa
dc.relation.urihttps://ard.bmj.com/content/74/Suppl_2/693.1spa
dc.rights.accesRightsinfo:eu-repo/semantics/closedAccess
dc.rights.accesoBloqueado (Texto referencial)spa
dc.sourceAnnals of the Rheumatic Diseasesspa
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subject.keywordCalprotectinspa
dc.subject.keywordleucocyte proteinspa
dc.subject.keywordrheumatoid arthritisspa
dc.subject.keywordpatientsspa
dc.titleSAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitorsspa
dc.title.TranslatedTitleSAT0118 La calprotectina estratifica la actividad de la enfermedad mejor que los reactivos de fase aguda en pacientes con artritis reumatoide que reciben inhibidores del TNFspa
dc.typeconferenceObjecteng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaDocumento de conferenciaspa
Archivos
Colecciones
Conferencia y eventos externos